Relationships among plasma dehydroepiandrosterone sulfate and cortisol levels, symptoms of dissociation, and objective performance in humans exposed to acute stress

Archives of General Psychiatry

Volumn 61, Issue 8, 2004, Pages 819-825

  Morgan III, Charles A ^a,b   Southwick, Steve ^a   Hazlett, Gary ^c   Rasmusson, Ann ^b   Hoyt, Gary ^b,e   Zimolo, Zoran ^a,b   Charney, Dennis ^d  

^a National Center for Posttraumatic Stress Disorder   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Psychol Applications Directorate   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e Training Group Pacific Navy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PRASTERONE SULFATE;

ADULT; ARMY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISSOCIATIVE DISORDER; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; MENTAL STRESS; NEUROTROPISM; NORMAL HUMAN; PROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; DEHYDROEPIANDROSTERONE SULFATE; DISSOCIATIVE DISORDERS; HUMANS; HYDROCORTISONE; LIFE CHANGE EVENTS; MALE; MILITARY PERSONNEL; PROBLEM SOLVING; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SALIVA; STRESS, PSYCHOLOGICAL; TASK PERFORMANCE AND ANALYSIS;

EID: 3543139554     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.61.8.819     Document Type: Article

References (54)

1. Nieschlag E, Loriaux DL, Ruder HJ, Zucker IR, Kirschner MA, Lipsett MB. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Endocrinol. 1973;57:123-134.
2. Majewska MD, Demirgoren S, Spivak CE, London ED. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 1990;526:143-146.
3. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol. 2000;21:1-56.
4. Melchior CL, Ritzmann RF. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav. 1994;47:437-441.
5. Robel P, Baulieu EE. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann N Y Acad Sci. 1995;774:82-110.
6. Roberts E. Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) as neural facilitators: effects on brain tissue in culture and on memory in young and old mice: a cyclic GMP hypothesis of action of DHEA and DHEAS in nervous system and other tissues. In: Kalimi M, Regelson W, eds. The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin, Germany: W de Gruyter; 1990:13-42.
7. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci U S A. 1998;95:1852-1857.
8. Kimonides VG, Spillantini MG, Sofroniew MV, Fawcett JW, Herbert J. Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience. 1999;89:429-436.
9. Fleshner M, Pugh CR, Tremblay D, Rudy JW. DHEA-S selectively impairs contextual-fear conditioning: support for the antiglucocorticoid hypothesis. Behav Neurosci. 1997;111:512-517.
10. Frye CA, Lacey EH. The neurosteroids DHEA and DHEAS may influence cognitive performance by altering affective state. Physiol Behav. 1999;66:85-92.
11. Labrie F, Belanger A, Cusan L, Gomez J-L, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab. 1997;82:2396-2402.
12. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59:551-555.
13. Orentreich N, Brind JL, Bogelman JH, Andres R, Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. 1992;75:1002-1004.
14. Sulcova J, Hill M, Starka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol. 1997;154:57-62.
15. Zumoff B, Walter L, Rosenfeld RS, Strain JJ, Degen K, Strain GW, Levin J, Fukushima D. Subnormal plasma adrenal androgen levels in men with uremia. J Clin Endocrinol Metab. 1980;51:801-805.
16. Floreani A, Titta M, Plebani M, Faggian D, Chiaramonte M, Naccarato R. Sex hormone changes in post-menopausal women with primary biliary cirrhosis (PBC) and with cryptogenic chronic liver disease. Clin Exp Obstet Gynecol. 1991;18:229-234.
17. Yamauchi A, Takei I, Kasuga A, Kitamura Y, Ohashi N, Nakano S, Takayama S, Nakamoto S, Katsukawa F, Saruta T. Depression of dehydroepiandrosterone in Japanese diabetic men: comparison between non-insulin dependent diabetes mellitus and impaired glucose tolerance. Eur J Endocrinol. 1996;135:101-104.
18. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HJ, Kwitervich PO, Pearson TA. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol. 1990;16:862-870.
19. Masi AT. Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? Clin Exp Rheumatol. 1995;13:227-240.
20. Scott LV, Salahuddin F, Cooney J, Svec F, Dinan TG. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord. 1999;54:129-137.
21. Goodyer IM, Herbert J, Altham PME, Pearson J, Secher SM, Shiers HM. Adrenal secretion during major depression in 8-16 year olds, I: altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med. 1996;26:245-256.
22. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 1997;41:311-318.
23. Micheal A, Jenaway A, Paykel ES, Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry. 2000;48:989-995.
24. Fava M, Rosenbaum JF, MacLaughlin RA, Tesar GE, Pollack MH, Cohen LS, Hirsch M. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res. 1989;28:345-350.
25. Zumoff B, Walsh BT, Katz JL, Levin J, Rosenfeld RS, Kream J, Weiner H. Subnormal plasma dehydroepiandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metab. 1983;56:668-672.
26. Oades RD, Schepker R. Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology. 1994;19:373-385.
27. Soendergaard HP, Hansson LO, Theorell T. Elevated blood levels of dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in Sweden. Psychother Psychosom. 2002;71:298-303.
28. Goodyer IM, Herbert J, Altham PME. Adrenal steroid secretion and major depression in 8-16 year olds, III: influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol Med. 1998;28:253-255.
29. Soendergaard HP, Theorell T. A longitudinal study of hormonal reactions accompanying life events in recently resettled refugees. Psychother Psychosom. 2003;72:49-58.
30. Cruess DG, Antoni MH, Kumar M, Ironson G, McCabe P, Fernandez JB, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/ DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men. Psychoneuroendocrinology. 1999;24:537-549.
31. Morgan CA III, Wang S, Mason J, Hazlett G, Fox P, Southwick SM, Charney DS, Greenfield G. Hormone profiles in humans experiencing military survival training. Biol Psychiatry. 2000;47:891-901.
32. Morgan CA III, Wang S, Southwick SM, Rasmusson A, Hauger R, Charney DS. Plasma neuropeptide-Y in humans exposed to military survival training. Biol Psychiatry. 2000;47:902-909.
33. Morgan CA III, Wang S, Hazlett G, Rassmusson A, Anderson G, Charney DS. Relationships among cortisol, catecholamines, neuropeptide Y and human performance during uncontrollable stress. Psychosom Med. 2001;63:412-442.
34. Morgan CA III, Hazlett G, Wang S, Richardson G, Schnurr P, Southwick SM. Symptoms of dissociation in humans experiencing acute uncontrollable stress: a prospective investigation. Am J Psychiatry. 2001;158:1239-1247.
35. Marmar CR, Weiss DS, Metzler TJ, Delucchi KL, Best SR, Wentworth KA. Longitudinal course and predictors of continuing distress following critical incident exposure in emergency services personnel. J Nerv Ment Dis. 1999;187:15-22.
36. Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, Mazure CM. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress. 1998;11:125-136.
37. Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methly-D-aspartate receptor antagonists. Arch Gen Psychiatry. 2000;57:270-276.
38. Wolf OT, Kudielka BM, Hellhammer DH, Hellhammer J, Kirschbaum C. Opposing effects of DHEA replacement in elderly subjects on declarative memory and attention after exposure to a laboratory stressor. Psychoneuroendocrinology. 1998;23:617-629.
39. Hortnagl H, Berger ML, Havelec L, Hornykeiwicz O. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A). J Neurosci. 1993;13:2939-2945.
40. Demirgoren S, Majewska MD, Spivak CE, London ED. Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABA A receptor. Neuroscience. 1991;45:127-135.
41. Kishimoto Y, Hoshi M. Dehydroepiandrosterone sulphate in rat brain: incorporation from blood and metabolism in vivo. J Neurochem. 1972;19:2207-2215.
42. Blauer KL, Poth M, Rogers W, Bernton E. DHEA antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology. 1991;129:3174-3179.
43. Browne ES, Wright BE, Porter JR, Svec F. Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci. 1992;303:366-371.
44. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo, II: dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol. 1990;20:793-802.
45. Morfin R, Starka L. Neurosteroid 7-hydroxylation products in the brain. Int Rev Neurobiol. 2001;46:79-95.
46. Rose KA, Stapleton G, Dott K, Kieny MP, Best R, Schwarz M, Russell DW, Bjorkheim I, Secki J, Lathe R. Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxy dehydroepiandrosterone and 7α-hydroxy pregnenolone. Proc Natl Acad Sci U S A. 1997;94:4925-4930.
47. Bastianetto S, Ramassamy C, Poirier J, Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Mol Brain Res. 1999;66:35-41.
48. Kaminska M, Harris J, Gilsbers K, Dubrovsky B. Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP: implications for depression. Brain Res Bull. 2000;52:229-234.
49. Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci. 2002;16:445-453.
50. Zhang L, Li B, Ma W, Barker JL, Chang YH, Zhao W, Rubinow DR. Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Brain Res Mol Brain Res. 2002;98:58-66.
51. Majewska MD, Schwartz RD. Pregnenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain? Brain Res. 1987;404:355-360.
52. Majewska MD, Mienville J-M, Vicini S. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett. 1988;90:279-284.
53. Gavish M, Laor N, Bidder M, Fisher D, Fonia O, Muller U, Reiss A, Wolmer L, Karp L, Weizman R. Altered platelet peripheral type benzodiazepine receptor in posttraumatic stress disorder. Neuropsychopharmacology. 1996;14:181-186.
54. Jakubowicz DJ, Beer NA, Beer RM, Nestler JE. Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. J Clin Endocrinol Metab. 1995;80:3373-3376.